|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 31/12 | (2006.01) |
| (11) | Number of the document | 3702373 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20154386.5 |
| Date of filing the European patent application | 2013-09-13 | |
| (97) | Date of publication of the European application | 2020-09-02 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-24 |
| (46) | Date of publication of the claims translation | 2022-11-10 |
| (72) |
SONG, Jing , CN
LI, Kang , CN
ZHANG, Tong , CN
XU, Lanlan , CN
LIU, Qi , CN
PENG, Hao , CN
|
| (73) |
BeOne Medicines I GmbH ,
Aeschengraben 27, 4051 Basel,
CH
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-PD1 antikūnai ir jų naudojimas terapijai ir diagnostikai |
| ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS |
| Payment date | Validity (years) | Amount | |
| 2025-08-27 | 13 | 289.00 EUR |
| 2026-09-13 |